implantable cardioverter defibrillator (ICD)

From Aaushi
Jump to navigation Jump to search

Introduction

Implantable device to automatically detect & terminate ventricular tachycardia or ventricular fibrillation by delivering or more shocks to the heart to terminate the arrhythmia.

Indications

* The multicenter automatic defibrillator implantation trial (MADIT) showed better survival in patients with inducible ventricular tachycardia with implanted defibrillators than those treated with anti-arrhythmic agents.

# ICD may benefit patients with history of myocardial infarction & low LV ejection fractions (< 30-35%) > 40 days after MI.[3][5]

* may benefit younger patients (HR=0.65) but not older patients[11]

# Life expectancy should be > 1 year

Contraindications

* left ventricular function may recover[2]

Procedure

Complications

Management

Notes

More general terms

More specific terms

Additional terms

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 67, 68
  2. 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17, 19. American College of Physicians, Philadelphia 1998, 2009, 2012, 2015, 2022
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  3. 3.0 3.1 Journal Watch 22(9):67, 2002 Moss AJ et al, N Engl J Med 346:877, 2002
  4. Journal Watch 25(5):37-38, 2005 Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004 Dec 9;351(24):2481-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15590950
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20;352(3):225-37. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15659722
    McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005 Jan 20;352(3):222-4. No abstract available. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/15659721 <Internet> http://www.cms.hhs.gov/media/press/release/asp?Counter=1331
    Kadish A. Prophylactic defibrillator implantation--toward an evidence-based approach. N Engl J Med. 2005 Jan 20;352(3):285-7. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15659729
  5. 5.0 5.1 5.2 Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006 Jan 11;295(2):165-71. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16403928
    Page RL. Antiarrhythmic drugs for all patients with an ICD? JAMA. 2006 Jan 11;295(2):211-3. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16403933
  6. 6.0 6.1 6.2 Amin MS, Matchar DB, Wood MA, Ellenbogen KA. Management of recalled pacemakers and implantable cardioverter- defibrillators: a decision analysis model. JAMA. 2006 Jul 26;296(4):412-20. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16868299
  7. Torpy JM, Implantable Cardioverter-Defibrillators JAMA 2007, 297:1946
    Zimetbaum PJ A 59-year-old man considering implantation of a cardiac defibrillator JAMA 2007, 297:1946 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17473301
  8. 8.0 8.1 FDA MedWatch Oct 16, 2007 Medtronic Sprint Fidelis Defibrillator Leads http://www.fda.gov/medwatch/safety/2007/safety07.htm#Fidelis
  9. 9.0 9.1 Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, et al; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18387436
    Raitt MH. Implantable cardioverter-defibrillator shocks: a double-edged sword? J Am Coll Cardiol. 2008 Apr 8;51(14):1366-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18387437
  10. 10.0 10.1 Pouleur A-C et al. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 2010 Aug; 122:597. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20660803
  11. 11.0 11.1 11.2 Physician's First Watch, Nov 2, 2010 Massachessetts Medical Society http://www.jwatch.org Santangeli P et al, Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators Annals of Internal Medicine 2010, 153:592-599 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21041579 <Internet> http://www.annals.org/content/153/9/592.abstract
  12. 12.0 12.1 Al-Khatib SM et al. Non-evidence-based ICD implantations in the United States. JAMA 2011 Jan 5; 305:43. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21205965 <Internet> http://jama.ama-assn.org/content/305/1/43.full
    Kadish A and Goldberger J. Selecting patients for ICD implantation: Are clinicians choosing appropriately? JAMA 2011 Jan 5; 305:91. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21205971
  13. 13.0 13.1 Kolb CK et al. Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol 2003 Jun 4; 41:2054-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12798581
    Jilek C et al Safety of Screening Procedures With Hand-Held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices A Cross-sectional Analysis Annals of Internal Medicine November 1, 2011. 155(9):587-592 http://www.annals.org/content/155/9/587.abstract
  14. 14.0 14.1 Journal Watch Massachusetts Medical Society Journal Watch Cardiology November 30, 2011 http://cardiology.jwatch.org
  15. 15.0 15.1 Jilek C et al Safety of screening procedures with hand-held metal detectors among patients with implanted cardiac rhythm devices: A cross-sectional analysis. Ann Intern Med 2011 Nov 1; 155:587 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22041947
  16. 16.0 16.1 MacFadden DR et al. Sex differences in implantable cardioverter-defibrillator outcomes: Findings from a prospective defibrillator database. Ann Intern Med 2012 Feb 7; 156:195. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22312139
  17. 17.0 17.1 FDA News Release: September 28, 2012 FDA approves first subcutaneous heart defibrillator http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm321755.htm
  18. 18.0 18.1 18.2 Moss AJ et al for the MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012 Nov 6 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23131066 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1211107
  19. 19.0 19.1 Pavri BB et al. Reuse of explanted, resterilized implantable cardioverter- defibrillators: A cohort study. Ann Intern Med 2012 Oct 16; 157:542 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23070487
    Farmer P and Bukhman G. Reuse of medical devices and global health equity. Ann Intern Med 2012 Oct 16; 157:591 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23070493
  20. 20.0 20.1 Lampert R et al Arrhythmia/Electrophysiology. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators. Results of a Prospective, Multinational Registry. Circulation. May 21, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23690453 <Internet> http://circ.ahajournals.org/content/127/20/2021.full
  21. 21.0 21.1 Peterson PN et al. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA 2013 May 15; 309:2025 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23677314
  22. Crossley GH, Poole JE, Rozner MA et al The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011 Jul;8(7):1114-54. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21722856
  23. 23.0 23.1 Ruwald MH et al. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: The MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation with Cardiac Resynchronization Therapy). J Am Coll Cardiol 2013 Oct 8; 62:1343 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23770172
    Raitt MH. Inappropriate implantable defibrillator shocks: An adverse outcome that can be prevented. J Am Coll Cardiol 2013 Oct 8; 62:1351. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23770170
  24. 24.0 24.1 Hutsen L Routine Defibrillation Testing Not Required During ICD Implantation. Physician's First Watch, May 12, 2014 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
  25. 25.0 25.1 Al-Khatib SM et al. Association between prophylactic implantable cardioverter- defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. JAMA 2014 Jun 4; 311:2209. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24893088
  26. 26.0 26.1 Pokorney SD et al Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction. JAMA. 2015;313(24):2433-2440. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26103027 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=2338252
    Hauser RG Underutilization of Implantable Cardioverter-Defibrillators in Older Patients. JAMA. 2015;313(24):2429-2430 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26103025 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=2338231
  27. 27.0 27.1 Dudzinsk DM et al Case Records of the Massachusetts General Hospital. Case 19-2015. A 71-Year-Old Man with Chest Pain and Shortness of Breath. N Engl J Med. 2015 Jun 18;372(25):2438-46. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26083209 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcpc1415757
  28. Russo AM, Stainback RF, Bailey SR et al ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2013 Mar 26;61(12):1318-68 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23453819
  29. Greenspon AJ, Patel JD, Lau E et al 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21867833
  30. 30.0 30.1 30.2 Ranasinghe I, Parzynski CS, Freeman JV et al Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study. Ann Intern Med. Published online 3 May 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27135392 <Internet> http://annals.org/article.aspx?articleid=2520465
  31. 31.0 31.1 Swiryn A, Orlov MV, Benditt DG et al Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population. Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation. 2016;134:1130-1140. October 17, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27754946 <Internet> http://circ.ahajournals.org/content/134/16/1130
  32. 32.0 32.1 32.2 Young K, Fairchild DG Heart Groups Update Guidelines on Managing Ventricular Arrhythmias and Preventing Sudden Cardiac Death Physician's First Watch, Oc 31, 2017 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    JACC article
  33. 33.0 33.1 Nazarian S, Hansford R, Rahsepar AA Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices. N Engl J Med 2017; 377:2555-2564. December 28, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29281579 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1604267
  34. 34.0 34.1 Bansal N, Szpiro A, Reynolds K et al Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. JAMA Intern Med. Published online February 5, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29404570 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2671406
  35. 35.0 35.1 DeFilippis EM, Vaidya A, Braun D et al A Shocking Turn of Events. N Engl J Med. 2018 May 24;378(21):e29. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29791827 https://www.nejm.org/doi/full/10.1056/NEJMimc1710576
  36. 36.0 36.1 36.2 FDA Safety Communication. March 21m 2019 Cybersecurity Vulnerabilities Affecting Medtronic Implantable Cardiac Devices, Programmers, and Home Monitors: FDA Safety Communication. https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm633960.htm
  37. 37.0 37.1 Jukema JW, Timal RJ, Rotmans JI et al. Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients. Circulation 2019 Jun 4; 139:2628. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30882234
    Kaplan R, Passman R. Defibrillators don't deliver in dialysis. Circulation 2019 Jun 4; 139:2639. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31158000
  38. 38.0 38.1 Hajduk AM, Gurwitz JH, Tabada G et al. Influence of multimorbidity on burden and appropriateness of implantable cardioverter-defibrillator therapies. J Am Geriatr Soc 2019 Jul; 67:1370. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30892695
  39. 39.0 39.1 Knops RE et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med 2020 Aug 6; 383:526 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32757521 https://www.nejm.org/doi/10.1056/NEJMoa1915932
  40. 40.0 40.1 Greenberg JC, Altawil MR, Singh G Life Saving Therapy Inhibition by Phones Containing Magnets. Heart Rhythm. 2021. Jan 4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33418126 https://www.heartrhythmjournal.com/article/S1547-5271(20)31227-3/fulltext
  41. 41.0 41.1 Fery C et al. Magnetic field measurements of portable electronic devices: The risk inside pockets for patients with cardiovascular implantable devices. Circ Arrhythm Electrophysiol 2022 Mar; 15:e010646 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35227069 https://www.ahajournals.org/doi/10.1161/CIRCEP.121.010646
  42. 42.0 42.1 Heidenreich PA et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Am Coll Cardiol 2022 Apr 1; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/35363499 Review. https://www.sciencedirect.com/science/article/abs/pii/S0735109721083959
  43. 43.0 43.1 Dressler DD MRI in Patients with Non-MRI-Conditional Implantable Defibrillators. NEJM Journal Watch. Feb 2, 2023. https://www.jwatch.org
    Ra J et al. Implantable defibrillator system shock function, mortality, and cause of death after magnetic resonance imaging. Ann Intern Med 2023 Jan 31; [e-pub] https://www.acpjournals.org/doi/10.7326/M22-2653
  44. 44.0 44.1 Al-Khatib SM, Stevenson WG, Ackerman MJ et al 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29097296 Free article. Review.
  45. 45.0 45.1 Myerburg RJ Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008;359:2245-53 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19020326